Pharmacokinetics, Safety, and 48-Week Efficacy of Oral Raltegravir in HIV-1-Infected Children Aged 2 Through 18 Years
- DOI
- 10.1093/cid/cit696
- Published
- 2013-10-21
- Container
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1093/cid/cit696,
title = {Pharmacokinetics, Safety, and 48-Week Efficacy of Oral Raltegravir in HIV-1-Infected Children Aged 2 Through 18 Years},
author = {S. Nachman and N. Zheng and E. P. Acosta and H. Teppler and B. Homony and B. Graham and T. Fenton and X. Xu and L. Wenning and S. A. Spector and L. M. Frenkel and C. Alvero and C. Worrell and E. Handelsman and A. Wiznia and Unknown and H. Moultrie and G. Kindra and M. A. Sanders and R. Williams and J. Jensen and M. Acevedo and L. Fabregas and A. Jurgrau and M. Foca and A. Higgins and J. G. Deville and K. Nielsen-Saines and M. F. Carter and J. Swetnam and J. Wilson and M. Donnelly and S. Akleh and M. Rigaud and A. Kaul and N. Patel and A. Gaur and L. J. Utech and E. Cardoso and A. M. Moreira and B. Santos and R. Bobat and R. Mngqibisa and M. Burey and J. Abadi and M. Rosenberg and K. Luzuriaga and D. Picard and J. Pagano-Therrien and S. Dittmer and H. N. Ndiweni and A. Patel and M. DelRey and C. McMullen-Jackson and M. E. Paul and A. Melvin and C. Venema-Weiss and J. Lane and C. Beneri and D. Ferraro and E. Infanzon and J. B. McAuley and M. Aziz and M. McNichols and S. Pelton and D. McLaud and D. Clarke and S. Zeichner and A. Akar and D. Thompson and S. D. Douglas and R. M. Rutstein and C. A. Vincent and M. E. Vachon and M. Cavallo and M. U. Purswani and G. Masheto and A. Ogwu and T. Kakhu and R. M. Viani and A. Darcey and K. Norris and S. K. Burchett and C. Kneut and N. Karthas and D. Casey and P. Emmanuel and J. Lujan-Zilbermann and S. Rana and P. Houston and M. Mengistab and M. Rathore and A. Mirza and T. Gayton and E. Barr and J. Dunn and K. Hahn and Z. Eysallenne and F. S. Howard and K. Graham and M. D. Negra and W. Queiroz and Y. C. Lian and D. Wara and T. Ruel and R. VanDyke and P. Reilly and S. Bradford and A. J. van Rensburg and E. Dobbels and M. Bester and M. Bamji and S. Paul and M. Sarza and A. Kovacs and J. Homans and L. Spencer and C. Hofer and T. Abreu and R. Oliveira and E. C. Joao and J. Pinto and F. Ferreira and F. Kakehasi and M. C. Cervi and M. D. L. Isaac and M. H. Losso and E. Stankievich and I. Foradori and D. Tucker and J. Church and M. Belzer and J. Hopkins and J. Ellen and A. Agwu and B. Laurel},
year = {2013},
journal = {Clinical Infectious Diseases},
doi = {10.1093/cid/cit696},
url = {https://doi.org/10.1093/cid/cit696}
}RIS
TY - JOUR TI - Pharmacokinetics, Safety, and 48-Week Efficacy of Oral Raltegravir in HIV-1-Infected Children Aged 2 Through 18 Years AU - S. Nachman AU - N. Zheng AU - E. P. Acosta AU - H. Teppler AU - B. Homony AU - B. Graham AU - T. Fenton AU - X. Xu AU - L. Wenning AU - S. A. Spector AU - L. M. Frenkel AU - C. Alvero AU - C. Worrell AU - E. Handelsman AU - A. Wiznia AU - Unknown AU - H. Moultrie AU - G. Kindra AU - M. A. Sanders AU - R. Williams AU - J. Jensen AU - M. Acevedo AU - L. Fabregas AU - A. Jurgrau AU - M. Foca AU - A. Higgins AU - J. G. Deville AU - K. Nielsen-Saines AU - M. F. Carter AU - J. Swetnam AU - J. Wilson AU - M. Donnelly AU - S. Akleh AU - M. Rigaud AU - A. Kaul AU - N. Patel AU - A. Gaur AU - L. J. Utech AU - E. Cardoso AU - A. M. Moreira AU - B. Santos AU - R. Bobat AU - R. Mngqibisa AU - M. Burey AU - J. Abadi AU - M. Rosenberg AU - K. Luzuriaga AU - D. Picard AU - J. Pagano-Therrien AU - S. Dittmer AU - H. N. Ndiweni AU - A. Patel AU - M. DelRey AU - C. McMullen-Jackson AU - M. E. Paul AU - A. Melvin AU - C. Venema-Weiss AU - J. Lane AU - C. Beneri AU - D. Ferraro AU - E. Infanzon AU - J. B. McAuley AU - M. Aziz AU - M. McNichols AU - S. Pelton AU - D. McLaud AU - D. Clarke AU - S. Zeichner AU - A. Akar AU - D. Thompson AU - S. D. Douglas AU - R. M. Rutstein AU - C. A. Vincent AU - M. E. Vachon AU - M. Cavallo AU - M. U. Purswani AU - G. Masheto AU - A. Ogwu AU - T. Kakhu AU - R. M. Viani AU - A. Darcey AU - K. Norris AU - S. K. Burchett AU - C. Kneut AU - N. Karthas AU - D. Casey AU - P. Emmanuel AU - J. Lujan-Zilbermann AU - S. Rana AU - P. Houston AU - M. Mengistab AU - M. Rathore AU - A. Mirza AU - T. Gayton AU - E. Barr AU - J. Dunn AU - K. Hahn AU - Z. Eysallenne AU - F. S. Howard AU - K. Graham AU - M. D. Negra AU - W. Queiroz AU - Y. C. Lian AU - D. Wara AU - T. Ruel AU - R. VanDyke AU - P. Reilly AU - S. Bradford AU - A. J. van Rensburg AU - E. Dobbels AU - M. Bester AU - M. Bamji AU - S. Paul AU - M. Sarza AU - A. Kovacs AU - J. Homans AU - L. Spencer AU - C. Hofer AU - T. Abreu AU - R. Oliveira AU - E. C. Joao AU - J. Pinto AU - F. Ferreira AU - F. Kakehasi AU - M. C. Cervi AU - M. D. L. Isaac AU - M. H. Losso AU - E. Stankievich AU - I. Foradori AU - D. Tucker AU - J. Church AU - M. Belzer AU - J. Hopkins AU - J. Ellen AU - A. Agwu AU - B. Laurel PY - 2013 JO - Clinical Infectious Diseases DO - 10.1093/cid/cit696 UR - https://doi.org/10.1093/cid/cit696 ER -
APA
Nachman, S., Zheng, N., Acosta, E. P., Teppler, H., Homony, B., Graham, B., Fenton, T., Xu, X., Wenning, L., Spector, S. A., Frenkel, L. M., Alvero, C., Worrell, C., Handelsman, E., Wiznia, A., Unknown, Moultrie, H., Kindra, G., Sanders, M. A., Williams, R., Jensen, J., Acevedo, M., Fabregas, L., Jurgrau, A., Foca, M., Higgins, A., Deville, J. G., Nielsen-Saines, K., Carter, M. F., Swetnam, J., Wilson, J., Donnelly, M., Akleh, S., Rigaud, M., Kaul, A., Patel, N., Gaur, A., Utech, L. J., Cardoso, E., Moreira, A. M., Santos, B., Bobat, R., Mngqibisa, R., Burey, M., Abadi, J., Rosenberg, M., Luzuriaga, K., Picard, D., Pagano-Therrien, J., Dittmer, S., Ndiweni, H. N., Patel, A., DelRey, M., McMullen-Jackson, C., Paul, M. E., Melvin, A., Venema-Weiss, C., Lane, J., Beneri, C., Ferraro, D., Infanzon, E., McAuley, J. B., Aziz, M., McNichols, M., Pelton, S., McLaud, D., Clarke, D., Zeichner, S., Akar, A., Thompson, D., Douglas, S. D., Rutstein, R. M., Vincent, C. A., Vachon, M. E., Cavallo, M., Purswani, M. U., Masheto, G., Ogwu, A., Kakhu, T., Viani, R. M., Darcey, A., Norris, K., Burchett, S. K., Kneut, C., Karthas, N., Casey, D., Emmanuel, P., Lujan-Zilbermann, J., Rana, S., Houston, P., Mengistab, M., Rathore, M., Mirza, A., Gayton, T., Barr, E., Dunn, J., Hahn, K., Eysallenne, Z., Howard, F. S., Graham, K., Negra, M. D., Queiroz, W., Lian, Y. C., Wara, D., Ruel, T., VanDyke, R., Reilly, P., Bradford, S., Rensburg, A. J. V., Dobbels, E., Bester, M., Bamji, M., Paul, S., Sarza, M., Kovacs, A., Homans, J., Spencer, L., Hofer, C., Abreu, T., Oliveira, R., Joao, E. C., Pinto, J., Ferreira, F., Kakehasi, F., Cervi, M. C., Isaac, M. D. L., Losso, M. H., Stankievich, E., Foradori, I., Tucker, D., Church, J., Belzer, M., Hopkins, J., Ellen, J., Agwu, A., & Laurel, B. (2013). Pharmacokinetics, Safety, and 48-Week Efficacy of Oral Raltegravir in HIV-1-Infected Children Aged 2 Through 18 Years. Clinical Infectious Diseases. https://doi.org/10.1093/cid/cit696
Source records
- crossref · retrieved 2026-11-11T01:48:51.241Z